Arkolith/Stocks/ELITE PHARMACEUTICALS INC /NV/

ELITE PHARMACEUTICALS INC /NV/

Cross-source read

No active 13F manager changed its position in ELITE PHARMACEUTICALS INC /NV/ last quarter. Over the last 180 days, 1 insider bought and none sold, a net +$9K in open-market trades.

Tracked 13F holders
0
13F value (tracked)
$0
Smart-money readMixed
Net sellingNet buying
Funds · active managers, latest 13F
0 adding · 0 trimming
Insiders · Form 4 open-market, 180d
1 buying · 0 selling · +$9K
US House · STOCK Act, 180d
0 buying · 0 selling

The legs disagree, or only one of them leans.

Who owns ELITE PHARMACEUTICALS INC /NV/?

0 tracked 13F filers · ranked by shares held

Not held in any tracked 13F filing yet.

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$9K
1 insider
Net · 180d
$9K
1 open-market transaction
DateInsiderRoleActionSharesValue
Aug 19, 2026Dash Barry HDirectorBuy (P)30K$9K
Oct 2, 2025Plassche DouglasEVP OperationsSell (S)800K$496K
Aug 22, 2025Elite Pharmaceuticals Inc /Nv/EVP OperationsSell (S)500K$260K
Jul 10, 2025Kirkov KirkoChief Commercial OfficerBuy (P)16K$10K
Jul 8, 2025Plassche DouglasEVP OperationsSell (S)200K$116K
Oct 24, 2024Plassche DouglasSVP of OperationsSell (S)334K$170K
Oct 23, 2024Plassche DouglasSVP of OperationsSell (S)800K$392K
Mar 18, 2016Treppel JerryInsiderSell (S)258K$88K
Mar 17, 2016Treppel JerryInsiderSell (S)312K$109K
Feb 24, 2016Treppel JerryInsiderSell (S)100K$31K
Feb 22, 2016Treppel JerryInsiderSell (S)100K$32K
Feb 17, 2016Treppel JerryInsiderSell (S)50K$16K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
00–
Insiders
Form 4 open-market
10+$9K
US House
STOCK Act trades
00$0

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

1 most recent

Keep exploring

Connected entities for ELITE PHARMACEUTICALS INC /NV/

More on ELITE PHARMACEUTICALS INC /NV/

Browse more

All tracked stocks A–ZELITE PHARMACEUTICALS INC /NV/ insider filings13F funds A–Z
Build

Ask your agent what changed in ELITE PHARMACEUTICALS INC /NV/

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Get a key Compare plansWorkflow docs
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/ELPT/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for ELITE PHARMACEUTICALS INC /NV/.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + the live filing stream, joined for ELPT. Filings are public domain, sourced to SEC EDGAR.